TNDM
Tandem Diabetes Care Inc
16.50$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.0% | -2.6% | +15.8% | +63.7% | -22.2% | -17.1% | +2.7% | +3.6% | +16.5% | -14.9% | +3.0% | – | |
| – | +8.0% | -6.3% | +12.5% | +118.7% | -47.5% | -7.3% | -1.0% | +0.1% | +6.9% | -10.2% | -0.6% | – | |
| – | +3.9% | +1.5% | +19.1% | +10.5% | +26.3% | -24.8% | +6.3% | +6.7% | +24.7% | -18.3% | +5.8% | – | |
| – | +1.5% | +8.5% | +6.7% | +3.6% | +2.1% | +140.3% | -61.6% | -0.5% | -3.8% | -0.1% | +1.9% | – | |
| – | +8.1% | +5.1% | +4.6% | +5.7% | +6.2% | +7.6% | -3.7% | -1.1% | +4.3% | -4.3% | +3.2% | – | |
| – | +5.8% | +6.2% | +5.3% | +5.0% | +4.8% | +51.4% | -25.8% | -13.1% | +3.1% | -3.1% | +2.8% | – | |
| – | – | – | – | – | – | – | – | – | – | -310.2% | – | – | |
| – | -62.7% | +5.2% | -5.5% | +4.0% | -0.3% | -27.0% | +87.0% | -18.6% | +0.5% | -21.5% | +50.5% | – | |
| – | – | – | – | – | – | -763,156.3% | – | – | – | -524.5% | – | – | |
| – | -158.6% | – | -66.4% | -40.5% | -216.0% | – | -162.9% | – | – | -90.2% | -1.2% | – | |
| – | – | – | – | – | – | -17,392.2% | – | – | – | – | – | – | |
| – | – | – | – | – | – | -2,002.0% | – | – | – | -222.2% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.